Added to YB: 2025-08-28
Pitch date: 2025-08-26
DMP.DE [neutral]
Dermapharm Holding SE
+9.12%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally.
Market Cap
EUR 1.8B
Pitch Price
EUR 34.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
5.98
P/E
16.85
EV/Sales
1.37
Sector
Pharmaceuticals
Category
turnaround
Dermapharm (DMP): A Steady Hand in a Transition Year
DMP.DE (quick overview): Branded Pharma segment drives growth via allergology demand & international expansion while Other Healthcare & Parallel Import face restructuring headwinds. Arkopharma Spain showing early margin improvements. Mgmt maintains FY guidance, confident in transition to higher-margin branded therapies & reduced parallel import dependency.
Read full article (2 min)